CU20120153A7 - Antígenos vacunales quiméricos contra el virus de la hepatitis c - Google Patents
Antígenos vacunales quiméricos contra el virus de la hepatitis cInfo
- Publication number
- CU20120153A7 CU20120153A7 CUP2012000153A CU20120153A CU20120153A7 CU 20120153 A7 CU20120153 A7 CU 20120153A7 CU P2012000153 A CUP2012000153 A CU P2012000153A CU 20120153 A CU20120153 A CU 20120153A CU 20120153 A7 CU20120153 A7 CU 20120153A7
- Authority
- CU
- Cuba
- Prior art keywords
- virus
- antigens
- chimeric
- chemical
- against hepatitis
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 241000711549 Hepacivirus C Species 0.000 title abstract 4
- 239000000126 substance Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24271—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención describe antígenos vacunales quiméricos contra el virus de la hepatitis C (VHC) que comprenden regiones seleccionadas de diferentes antígenos de dicho virus, las que se ubican en un orden determinado dentro del polipéptido. Dichos antígenos quiméricos, además, pueden incluir epitopos específicos para linfocitos T auxiliadores, diseñados de forma artificial. Los antígenos quiméricos, así como las composiciones vacunales resultantes, son aplicables a la esfera de la medicina y la industria farmacéutica, y tienen un uso profiláctico y/o terapéutico contra el VHC. Las composiciones vacunales de la invención generan una respuesta inmune potente y de amplio espectro contra diferentes antígenos de dicho virus, con un mínimo de componentes.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20120153A CU24112B1 (es) | 2012-11-05 | 2012-11-05 | Antígenos vacunales quiméricos contra el virus de la hepatitis c |
RU2015121429A RU2639504C2 (ru) | 2012-11-05 | 2013-10-28 | Химерные антигены для вакцины против вируса гепатита с |
IN3925DEN2015 IN2015DN03925A (es) | 2012-11-05 | 2013-10-28 | |
CA2901346A CA2901346C (en) | 2012-11-05 | 2013-10-28 | Chimeric vaccine antigens against hepatitis c virus |
EP13801461.8A EP2915544B1 (en) | 2012-11-05 | 2013-10-28 | Chimeric vaccine antigens against hepatitis c virus |
CN201380064380.9A CN104837498B (zh) | 2012-11-05 | 2013-10-28 | 针对丙型肝炎病毒的嵌合疫苗抗原 |
US14/440,443 US9676825B2 (en) | 2012-11-05 | 2013-10-28 | Chimeric vaccine antigens against hepatitis C virus |
PCT/CU2013/000006 WO2014067498A1 (es) | 2012-11-05 | 2013-10-28 | Antígenos vacunales quiméricos contra el virus de la hepatitis c |
ES13801461.8T ES2644801T3 (es) | 2012-11-05 | 2013-10-28 | Antígenos de vacuna quimérica contra el virus de la hepatitis c |
MX2015005651A MX358507B (es) | 2012-11-05 | 2013-10-28 | Antigenos vacunales quimericos contra el virus de la hepatitis c. |
AU2013339846A AU2013339846B2 (en) | 2012-11-05 | 2013-10-28 | Chimeric vaccine antigens against hepatitis C virus |
JP2015540044A JP6259831B2 (ja) | 2012-11-05 | 2013-10-28 | C型肝炎ウイルスに対するキメラワクチン抗原 |
KR1020157012656A KR102093495B1 (ko) | 2012-11-05 | 2013-10-28 | C형 간염 바이러스에 대한 키메라 백신 항원 |
ARP130104019A AR093341A1 (es) | 2012-11-05 | 2013-11-04 | Antigenos vacunales quimericos contra el virus de la hepatitis c |
ZA2015/03036A ZA201503036B (en) | 2012-11-05 | 2015-05-04 | Chimeric vaccine antigens against hepatitis c virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20120153A CU24112B1 (es) | 2012-11-05 | 2012-11-05 | Antígenos vacunales quiméricos contra el virus de la hepatitis c |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20120153A7 true CU20120153A7 (es) | 2014-06-27 |
CU24112B1 CU24112B1 (es) | 2015-08-27 |
Family
ID=49724426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20120153A CU24112B1 (es) | 2012-11-05 | 2012-11-05 | Antígenos vacunales quiméricos contra el virus de la hepatitis c |
Country Status (15)
Country | Link |
---|---|
US (1) | US9676825B2 (es) |
EP (1) | EP2915544B1 (es) |
JP (1) | JP6259831B2 (es) |
KR (1) | KR102093495B1 (es) |
CN (1) | CN104837498B (es) |
AR (1) | AR093341A1 (es) |
AU (1) | AU2013339846B2 (es) |
CA (1) | CA2901346C (es) |
CU (1) | CU24112B1 (es) |
ES (1) | ES2644801T3 (es) |
IN (1) | IN2015DN03925A (es) |
MX (1) | MX358507B (es) |
RU (1) | RU2639504C2 (es) |
WO (1) | WO2014067498A1 (es) |
ZA (1) | ZA201503036B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3319997A4 (en) * | 2015-07-07 | 2019-01-23 | The Governors of the University of Alberta | IMMUNOGENIC COMPOSITIONS BASED ON HEPATITIS C VIRUS AND METHODS OF USE |
CN109963587A (zh) * | 2016-09-21 | 2019-07-02 | 艾伯塔大学理事会 | 丙型肝炎病毒免疫原性组合物及其使用方法 |
AU2018258575A1 (en) | 2017-04-27 | 2019-11-07 | The Johns Hopkins University | Hepatitis C virus gene sequences and methods of use therefor |
WO2019173925A1 (en) * | 2018-03-16 | 2019-09-19 | The Governors Of The University Of Alberta | Hepatitis c virus peptide compositions and methods of use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001037869A1 (en) | 1999-11-19 | 2001-05-31 | Csl Limited | Vaccine compositions |
US6544780B1 (en) * | 2000-06-02 | 2003-04-08 | Genphar, Inc. | Adenovirus vector with multiple expression cassettes |
CU23496A1 (es) * | 2004-09-03 | 2010-02-23 | Ct Ingenieria Genetica Biotech | Composición vacunal contra el virus de la hepatitis c |
CA2636032C (en) * | 2006-01-04 | 2016-04-12 | Novartis Vaccines And Diagnostics, Inc. | Activation of hcv-specific t cells |
US7256008B2 (en) | 2006-01-06 | 2007-08-14 | Abbott Laboratories | Determination of concentration of FK778 by competitive immunoassay |
WO2009056535A2 (en) * | 2007-10-29 | 2009-05-07 | Genimmune N.V. | Methods and kits for inducing a ctl response using a prime boost regimen |
CN102016026B (zh) * | 2008-04-25 | 2014-07-02 | 东丽株式会社 | 含有来自丙型肝炎病毒的嵌合基因的核酸 |
EP2331125A4 (en) * | 2008-09-19 | 2013-03-27 | Globeimmune Inc | IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS |
US20110311550A1 (en) * | 2008-10-24 | 2011-12-22 | The Scripps Research Institute | Agents for hcv treatment |
-
2012
- 2012-11-05 CU CU20120153A patent/CU24112B1/es active IP Right Grant
-
2013
- 2013-10-28 CA CA2901346A patent/CA2901346C/en not_active Expired - Fee Related
- 2013-10-28 EP EP13801461.8A patent/EP2915544B1/en active Active
- 2013-10-28 KR KR1020157012656A patent/KR102093495B1/ko active IP Right Grant
- 2013-10-28 WO PCT/CU2013/000006 patent/WO2014067498A1/es active Application Filing
- 2013-10-28 MX MX2015005651A patent/MX358507B/es active IP Right Grant
- 2013-10-28 RU RU2015121429A patent/RU2639504C2/ru not_active IP Right Cessation
- 2013-10-28 CN CN201380064380.9A patent/CN104837498B/zh active Active
- 2013-10-28 IN IN3925DEN2015 patent/IN2015DN03925A/en unknown
- 2013-10-28 US US14/440,443 patent/US9676825B2/en active Active
- 2013-10-28 JP JP2015540044A patent/JP6259831B2/ja not_active Expired - Fee Related
- 2013-10-28 AU AU2013339846A patent/AU2013339846B2/en not_active Ceased
- 2013-10-28 ES ES13801461.8T patent/ES2644801T3/es active Active
- 2013-11-04 AR ARP130104019A patent/AR093341A1/es unknown
-
2015
- 2015-05-04 ZA ZA2015/03036A patent/ZA201503036B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN104837498A (zh) | 2015-08-12 |
ZA201503036B (en) | 2016-01-27 |
CA2901346A1 (en) | 2014-05-08 |
RU2639504C2 (ru) | 2017-12-21 |
CN104837498B (zh) | 2018-05-18 |
KR20150079694A (ko) | 2015-07-08 |
US20150307558A1 (en) | 2015-10-29 |
WO2014067498A1 (es) | 2014-05-08 |
AU2013339846A1 (en) | 2015-05-14 |
MX358507B (es) | 2018-08-22 |
EP2915544B1 (en) | 2017-08-09 |
CA2901346C (en) | 2019-04-23 |
JP2015536936A (ja) | 2015-12-24 |
CU24112B1 (es) | 2015-08-27 |
RU2015121429A (ru) | 2016-12-27 |
AU2013339846B2 (en) | 2017-08-17 |
ES2644801T3 (es) | 2017-11-30 |
US9676825B2 (en) | 2017-06-13 |
KR102093495B1 (ko) | 2020-03-26 |
EP2915544A1 (en) | 2015-09-09 |
JP6259831B2 (ja) | 2018-01-10 |
IN2015DN03925A (es) | 2015-10-02 |
AR093341A1 (es) | 2015-06-03 |
MX2015005651A (es) | 2015-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001610A1 (es) | Anticuerpos humanos para hemagglutinina de influenza | |
NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
CL2018000232A1 (es) | Mezcla de péptidos (divisional solicitud 201601405) | |
MX2019004913A (es) | Vacunas de nanoparticulas lipidicas que comprenden acido ribonucleico mensajero (arnm). | |
DOP2018000146A (es) | Anticuerpos neutralizadores del virus de inmunodeficiencia humana | |
IL259942A (en) | Antigens, vectors, preparations, methods and their use for the human immunodeficiency virus | |
CR20180174A (es) | Nuevos péptidos, combinaciones de péptidos y soportes para el uso en el tratamiento inmunoterapéutico de varios tipos de cáncer | |
EA201591164A1 (ru) | Вакцины против вируса гриппа и их применение | |
MX2012009581A (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
MX2015013235A (es) | Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer. | |
UY37456A (es) | Inmunoglobulinas y sus usos | |
AR102547A1 (es) | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso | |
MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
CU20180035A7 (es) | Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas | |
AR093341A1 (es) | Antigenos vacunales quimericos contra el virus de la hepatitis c | |
BR112017008952A2 (pt) | métodos e composições para vírus recombinantes da dengue para desenvolvimento de vacina e diagnóstico | |
EA201792512A1 (ru) | Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник | |
MX363149B (es) | Vacunas de nucleoproteina de la influenza. | |
IN2014DN09445A (es) | ||
MX2019007924A (es) | Vacunas contra la influenza. | |
WO2014152271A8 (en) | Viral proteins as immunomodulatory agents and vaccine components | |
ECSP18039827A (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
AR110106A1 (es) | Inmunoglobulinas y usos de estas | |
PT3584252T (pt) | Antígenos, vetores, composições para o vírus da imunodeficiência humana e métodos da sua utilização | |
AR096455A1 (es) | Vacuna para la malaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent |